Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine May 2009, 50 (5) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

Small-animal cardiovascular imaging: Tsui and Kraitchman review recent technologies, new applications, and promising translational aspects of experimental cardiovascular molecular investigations with MR, optical, CT, and radionuclide-based imaging.
Page 667

Figure

Quest for infection imaging: Palestro provides an overview of current studies and challenges in radionuclide labeling of leukocytes and previews 2 articles in this issue of JNM with innovative approaches to sensitive and specific in vivo detection of infection.
Page 671

List mode–driven gating in PET: Büther and colleagues evaluate several cardiac and respiratory gating methods designed to reduce motion effects in PET and describe a simple and easily implemented solution.
Page 674

Figure

PET in liver transplantation: Lee and colleagues investigate the ability of 18F-FDG PET to identify appropriate candidates for liver transplantation for hepatocellular carcinoma and to predict tumor recurrence after surgery.
Page 682

Figure

Imaging before microsphere embolization: Hamami and colleagues describe the use of 99mTc-macroaggregated albumin SPECT/CT for detection of gastrointestinal shunting before radioembolization with 90Y microspheres in patients with hepatocellular carcinoma.
Page 688

Figure

HRRT spatial resolution and accuracy: van Velden and colleagues compare the quantitative accuracy and spatial resolution of high-resolution research tomography with that of a clinical HR+ PET scanner in brain imaging of healthy volunteers.
Page 693

Novel D2 receptor radioligand: Otsuka and colleagues report on the kinetics and quantification of 11C-MNPA, a new agonist radioligand for PET imaging of the high-affinity state of dopamine D2 receptors in the human brain.
Page 703

Figure

PET in chromaffin-derived tumors: Taïeb and colleagues evaluate tracer uptake in patients with chromaffin-derived tumors, with results that suggest that 18F-FDG avidity in pheochromocytomas and paragangliomas can be considered a new “molecular imaging signature” of disease.
Page 711

Figure

Phase analysis for LV dyssynchrony: Boogers and colleagues validate a quantitative gated SPECT algorithm for phase analysis in myocardial perfusion detection of left ventricular dyssynchrony and compare the results with those from echocardiography using tissue Doppler imaging.
Page 718

Figure

Liquid gastric emptying: Ziessman and colleagues assess whether a 30-min study of clear liquid gastric emptying can add diagnostic value to a study of solid emptying alone in the detection of gastroparesis.
Page 726

131I and rhTSH in nontoxic goiter: Fast and colleagues explore optimal time intervals between recombinant human thyroid-stimulating hormone and radioiodine administration to enhance thyroid uptake in patients with symptomatic nontoxic goiter.
Page 732

Radiotracer imaging in breast cancer: Lee and colleagues provide the second in a series of educational overviews of the current role of radiotracer imaging in breast cancer, focusing on management strategies, newer nonnuclear techniques, and future directions.
Page 738

11C-Rolipram binding in conscious rats: Itoh and colleagues measure the binding site density and radioligand affinity of this selective inhibitor of a key intracellular messenger in the rat brain and evaluate the effects of anesthesia in small-animal PET.
Page 749

Figure

sr39tk PET imaging: Johnson and colleagues determine the minimum number of human simplex virus type-1 thymidine kinase sr39tk–expressing tumor cells needed for 18F-FBHG PET detection and describe the potential for monitoring therapeutic gene expression in metastatic disease.
Page 757

Figure

Cell-based therapy for osteoporosis: Lo and colleagues report on the use of fibroblasts in combination with platelet-rich plasma to achieve cell-based bone regeneration in osteoporotic mice and on monitoring regeneration with fluorescence imaging.
Page 765

Figure

18F-FBnTP apoptosis detection: Madar and colleagues characterize the ability of the novel PET voltage sensor 18F-FBnTP to quantify the time-dependent apoptotic action of the taxanes paclitaxel and docetaxel in vitro and in vivo.
Page 774

99mTc-labeled recombinant Affibody: Ahlgren and colleagues describe the characteristics and potential advantages of the Affibody molecule 99mTc-ZHER2:2395-Cys as a promising tracer for SPECT visualization of human epidermal growth factor receptor type-2 expression in malignant tumors.
Page 781

Peptide-based imaging of inflammation: Locke and colleagues detail the synthesis and validation of a new, highly potent 64Cu-labeled peptide, cFLFLF-PEG-64Cu, that targets the formyl peptide receptor on leukocytes.
Page 790

Figure

Imaging P-gp inhibition in pregnancy: Eyal and colleagues test in primates the feasibility of whole-body PET for simultaneous, serial, noninvasive imaging of P-glycoprotein activity and inhibition in multiple maternal organs and the placenta.
Page 798

Brain imaging with 11C-dLop: Seneca and colleagues investigate whether this radiolabeled metabolite of loperamide is a promising PET tracer to study the function of P-glycoprotein at the blood–brain barrier in humans.
Page 807

Figure

11C-NPA biodistribution and dosimetry: Laymon and colleagues report on the whole-body distribution of this dopamine agonist PET tracer and resulting absorbed radiation doses in human subjects.
Page 814

Dosimetry of 18F-GE067: Koole and colleagues characterize the biodistribution and dosimetry of 18F-GE067, a newly developed radioligand for PET visualization and quantification of amyloid burden, in healthy elderly men and women.
Page 818

Distinguishing infection from inflammation: Liberatore and colleagues describe methods for 99mTc labeling of human β-defensin-3, an antimicrobial peptide with bactericidal effects, for evaluation of infection in experimental studies.
Page 823

Figure

PET after liver transplantation: Tsuji and colleagues explore the efficacy of a method for semiquantitative 18F-FDG PET detection of acute allograft rejection in a rodent model.
Page 827

ON THE COVER

The biodistribution and dosimetry of 18F-flutemetamol, a newly developed radioligand to visualize and quantify amyloid burden, have been characterized. Here, PET slices through the brain of a healthy subject (top) and a patient with Alzheimer disease (bottom) show the distribution of uptake. Specific uptake is present in gray matter in patients, and aspecific uptake is seen in white matter, pons, and thalamus. Variability in dosimetry between subjects was relatively low.

See page 821.

Figure
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (5)
Journal of Nuclear Medicine
Vol. 50, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine May 2009, 50 (5) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine May 2009, 50 (5) 11A-12A;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Recent Advances in Small-Animal Cardiovascular Imaging
  • Radionuclide Imaging of Infection: In Search of the Grail
  • Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma
  • SPECT/CT with 99mTc-MAA in Radioembolization with 90Y Microspheres in Patients with Hepatocellular Cancer
  • HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study
  • Quantitative PET Analysis of the Dopamine D2 Receptor Agonist Radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the Human Brain
  • 18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
  • Quantitative Gated SPECT–Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy
  • The Added Diagnostic Value of Liquid Gastric Emptying Compared with Solid Emptying Alone
  • Optimizing 131I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter: Evidence from a Prospective, Randomized, Double-Blind Study
  • The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2—Response to Therapy, Other Indications, and Future Directions
  • PET Measurement of the In Vivo Affinity of 11C-(R)-Rolipram and the Density of Its Target, Phosphodiesterase-4, in the Brains of Conscious and Anesthetized Rats
  • Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor
  • Transplantation of Embryonic Fibroblasts Treated with Platelet-Rich Plasma Induces Osteogenesis in SAMP8 Mice Monitored by Molecular Imaging
  • Detection and Quantification of the Evolution Dynamics of Apoptosis Using the PET Voltage Sensor 18F-Fluorobenzyl Triphenyl Phosphonium
  • Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
  • A Novel Neutrophil-Specific PET Imaging Agent: cFLFLFK-PEG-64Cu
  • Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate
  • Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein
  • Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET
  • Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
  • Microbial Targeting of 99mTc-Labeled Recombinant Human β-Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study
  • 18F-FDG PET for Semiquantitative Evaluation of Acute Allograft Rejection and Immunosuppressive Therapy Efficacy in Rat Models of Liver Transplantation
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire